Patent Insight into the Development of Therapeutic Strategies against Coronaviruses
Hai-Long Zhang1, *, Ai-Feng Zhou1, Yiqian Li2
Identifiers and Pagination:Year: 2021
First Page: 93
Last Page: 100
Publisher Id: TOCOVIDJ-1-93
Article History:Received Date: 3/3/2021
Revision Received Date: 25/5/2021
Acceptance Date: 21/6/2021
Electronic publication date: 30/09/2021
Collection year: 2021
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Coronaviruses are a group of RNA viruses, which cause diseases in humans. The emergence of COVID-19, has caused a global pandemic. It is focused on developing an effective therapeutic strategy against COVID-19. To better understand the development and evolution of therapeutic strategies against coronaviruses, we conducted US granted patents analysis. The results showed vaccines played a leading role in therapies against coronaviruses. Both attenuated vaccines and recombinant genetic vaccines were very important approaches in vaccine development against coronaviruses. It is not a rapid approach to develop peptide drugs against COVID-19 or future novel coronaviruses. The study was the first one to show the development and evolution in therapeutic strategies against coronaviruses based on patent insight. The present study provides a new insight into the development of therapeutic strategies against coronaviruses.